Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Implications for Management of PET Amyloid Classification Technology

Authors not listed

University of Utah · 2016

Abstract

The main purpose of this study is to explore the impact of an amyloid positron emission tomography and computed tomography (PET/CT) scan on physician diagnosis and management, including drug management and care practices, for patients with a diagnosis of cognitive impairment. This study also intends to capture specific patient-reported outcomes related to patient burden, confidence and satisfaction. The hypothesis is that to aid early diagnosis, individuals with a diagnostically uncertain etiology for their dementia will benefit from knowledge of amyloid plaque burden status, through an alteration of patient diagnosis and management, which will lead to significant changes in patient and care partner reported outcomes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2016). Implications for Management of PET Amyloid Classification Technology. <em>University of Utah</em>. https://clinicaltrials.gov/study/NCT02778971
Vancouver
Anonymous. Implications for Management of PET Amyloid Classification Technology. University of Utah. 2016.
BibTeX
@misc{anon2016Implic, title = {Implications for Management of PET Amyloid Classification Technology}, author = {Anonymous}, journal = {University of Utah}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings